株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

がん免疫療法の世界市場:将来展望

Global Cancer Immunotherapy Market Outlook 2027

発行 Research Nester 商品コード 750793
出版日 ページ情報 英文 370 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.74円で換算しております。
Back to Top
がん免疫療法の世界市場:将来展望 Global Cancer Immunotherapy Market Outlook 2027
出版日: 2018年10月01日 ページ情報: 英文 370 Pages
概要

当レポートでは、世界のがん免疫療法の関連市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、全体的な市場動向 (市場規模・成長率) の見通し (今後10年間分)、技術別・エンドユーザー別および地域別の詳細動向、主要企業のプロファイルなどを調査しております。

第1章 分析手法

第2章 市場の定義、前提条件、略語一覧

第3章 市場の分類

第4章 エグゼクティブ・サマリー

第5章 がん免疫療法:製品概要

第6章 主要国の市場

第7章 がん免疫療法市場:近年の傾向と動静、地域別

  • 新製品の開発
  • 企業合併・買収 (M&A)
  • 事業拡張、その他

第8章 各地域の平均価格動向の分析

第9章 がん免疫療法のバリューチェーンの分析

第10章 サプライチェーンの分析

  • 貿易協定・規制の動向:国別
  • 国際貿易の統計データ (輸出額/輸入額):国別

第11章 ポーターのファイブフォース分析

第12章 がん免疫療法市場:リスク分析

  • 需要リスク分析
  • 供給リスク分析

第13章 市場のダイナミクスとその影響度の分析

  • 成長促進要因
  • 課題
  • 傾向
  • 機会

第14章 世界市場の規模・成長率とその予測 (金額ベース、今後11年間分)

第15章 世界市場の予測:技術別

  • イントロダクション
  • 細胞免疫療法
    • 市場規模・成長率とその予測 (金額ベース、今後11年間分)
      • CAT-T細胞療法
      • 樹状細胞療法
  • モノクローナル抗体
    • 市場規模・成長率とその予測 (金額ベース、今後11年間分)
      • 非修飾 (Naked) モノクローナル抗体
      • コンジュゲート (結合) モノクローナル抗体
        • 放射標識抗体
        • 化学標識抗体
      • 二重特異性モノクローナル抗体
  • 免疫チェックポイント阻害剤
    • 市場規模・成長率とその予測 (金額ベース、今後11年間分)
      • PD-1/PD-L1阻害剤
      • CTLA-4阻害剤
  • がんワクチン
  • サイトカイン療法
  • 市場求心力の分析:技術別
  • 市場寄与率・市場シェア (BPS) 分析:技術別

第16章 世界市場の予測:エンドユーザー別

  • イントロダクション
  • 病院
  • 日帰り手術センター (ASC)
  • 診療所 (クリニック)
  • その他
  • 市場求心力:エンドユーザー別
  • 市場シェア (BPS) 分析:エンドユーザー別

第17章 世界市場の予測:地域別

  • 北米市場 (米国、カナダ)
    • マクロ経済指標とその影響
    • 国別分析
    • 技術別分析
    • エンドユーザー別分析
  • ラテンアメリカ市場 (メキシコ、ブラジルなど)
  • 欧州市場 (英国、ドイツ、フランス、イタリア、スペイン、ロシア、ポーランド、トルコ、ベネルクス諸国など)
  • アジア太平洋地域市場 (インド、中国、日本、オーストラリア、ニュージーランド、韓国など)
  • 中東・アフリカ市場 (湾岸協力会議 (GCC) 諸国、イスラエル、北部アフリカ、南アフリカなど)

第18章 競争環境

  • 主要企業のポジショニング:がん免疫療法市場
  • 企業プロファイル
    • AstraZeneca
      • 企業概要
      • 事業戦略
      • 主要製品
      • 財務実績
      • KPI (主要業績評価指標)
      • リスク分析
      • 近年の主な動向
      • 地域別のプレゼンス
      • SWOT分析
    • Merck & Co.
    • Novartis
    • Advaxis Inc
    • Bristol-Myers Squibb (BMS)
    • Bayer AG
    • Roche
    • Eli Lilly and Co.
    • Amgen Inc
    • Pfizer Inc

第19章 業界の手引き (地域別)、アナリストの提言

目次
Product Code: REP-ID-330

The global Cancer Immunotherapy market reached USD 42,584.18 Million in 2017 by registering a CAGR of 7.5% across the globe. Moreover, the market is expected to garner USD 86,678.7 Million by the end of 2027.

The global demand for Cancer Immunotherapy is increasing due to massive growth of healthcare industry across the globe. Further, increasing awareness about early diagnosis and advanced personalized medicine as a part of targeted therapy is key growth driver for global Cancer Immunotherapy market over the forecast period.

North America is slated to account for a share of 37.0% by 2027 in the Cancer Immunotherapy market. The growth in the region can be attributed to growing prevalence of various types of cancer. Increasing technological innovations in Cancer Immunotherapy is also expected to impel the growth of Cancer Immunotherapy market in the North America. U.S. is the prominent market driving the growth in the region.

Additionally, U.S. Cancer Immunotherapy market reached USD 13,392.7 Million in 2017 and is expected to reach USD 27,986.4 Million by the end of 2027, expanding at a CAGR of 7.7% over the forecast period i.e. 2018-2027. U.S. Cancer Immunotherapy market is expected to achieve Y-o-Y growth rate of 8.6% in 2027 as compared to previous year.

Europe market is expected to expand at CAGR of 7.8% during the forecast period i.e. 2018-2027. Europe Cancer Immunotherapy market is projected to reach to a valuation of USD 25,830.2 Million by the end of 2027 from USD 12,349.4 Million in 2017.

Global Cancer Immunotherapy market is segmented on the basis of technology into Cellular Immunotherapy, Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines & Cytokine Therapy. Among these segments, Monoclonal Antibodies segment (65.5% share in 2017) occupies the largest market of Cancer Immunotherapy across the globe. Further, global Monoclonal Antibodies segment is anticipated to reach USD 56,290.7 Million by the end of 2027 from USD 27,911.8 Million in 2017. Moreover, this segment is anticipated to flourish at a CAGR of 7.4% over the forecast period. In addition, Immune Checkpoint Inhibitors segment of Cancer Immunotherapy is expected to achieve Y-o-Y growth rate of 8.9% in 2027 as compared to previous year.

In addition this, global Cancer Immunotherapy market is also segmented by end-user. In end-user segment, the hospitals segment is estimated to capture the highest market share during the forecast period. This segment contributed around 65.3% market share of total Cancer Immunotherapy market in 2017. Further, this segment is projected to capture 64.2% market share by 2027. Further, hospitals segment is projected to achieve Y-o-Y growth rate of 8.1% in 2027 as compared to previous year.

Pfizer, Merck, Amgen and Roche are some of the prominent players of Cancer Immunotherapy market.

Table of Contents

1. Research Methodology

2. Market Definitions, Assumptions & Abbreviations

3. Market Taxonomy

4. Global Cancer Immunotherapy Market - Executive Summary

  • 4.1. Market Extracts by Technology
  • 4.2. Market Extracts by End User
  • 4.3. Market Extracts by Region

5. Cancer Immunotherapy Product Overview

  • 5.1. Product Timeline
  • 5.2. Features, by Product
  • 5.3. Pipeline Products

6. Top Countries with Highest Demand for Cancer Immunotherapy, 2017

7. Recent Changes and Development in Cancer Immunotherapy Market by Geography

  • 7.1. New Product Development
  • 7.2. Merger and Acquisition
  • 7.3. Expansion and others

8. Regional Average Pricing Analysis, 2017

9. Cancer Immunotherapy Value Chain Analysis

10. Supply Chain Analysis

  • 10.1. Global Trade Agreement and Regulations, By Country
  • 10.2. Global Trade Statistics (Exports and Imports), By Country

11. Porter's Five Force Model Analysis

12. Cancer Immunotherapy Market - Risk Analysis

  • 12.1. Demand Risk Analysis
  • 12.2. Supply Risk Analysis

13. Market Dynamics & Its Impact Analysis

  • 13.1. Growth Drivers
  • 13.2. Challenges
  • 13.3. Trends
  • 13.4. Opportunities

14. Global Cancer Immunotherapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027

15. Global Cancer Immunotherapy Market Segmentation Analysis By Technology

  • 15.1. Introduction
  • 15.2. Cellular Immunotherapy
    • 15.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 15.2.1.1. Market Value Increment Per Year, 2018-2027
        • 15.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
  • 15.3. Monoclonal Antibodies
    • 15.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 15.3.1.1. Market Value Increment Per Year, 2018-2027
        • 15.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
  • 15.4. Immune Checkpoint Inhibitors
    • 15.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 15.4.1.1. Market Value Increment Per Year, 2018-2027
        • 15.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
  • 15.5. Cancer Vaccines
    • 15.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 15.5.1.1. Market Value Increment Per Year, 2018-2027
  • 15.6. Cytokine Therapy
    • 15.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 15.6.1.1. Market Value Increment Per Year, 2018-2027
        • 15.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 15.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
  • 15.7. Market Attractiveness Analysis By Technology
  • 15.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology

16. Global Cancer Immunotherapy Market Segmentation Analysis By End User

  • 16.1. Introduction
  • 16.2. Hospitals
    • 16.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 16.2.1.1. Market Value Increment Per Year, 2018-2027
  • 16.3. Ambulatory Surgical Centers (ASCs)
    • 16.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 16.3.1.1. Market Value Increment Per Year, 2018-2027
  • 16.4. Clinics
    • 16.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 16.4.1.1. Market Value Increment Per Year, 2018-2027
  • 16.5. Others
    • 16.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 16.5.1.1. Market Value Increment Per Year, 2018-2027
  • 16.6. Market Attractiveness Analysis By End User
  • 16.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User

17. Global Cancer Immunotherapy Market Segmentation Analysis By Geography

  • 17.1. North America
    • 17.1.1. Macro-economic Indicators Impacting the Growth of North America Cancer Immunotherapy Market
    • 17.1.2. By Country
      • 17.1.2.1. The U.S. & Canada
        • 17.1.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.2.1.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.2.2. Market Attractiveness Analysis By Country
      • 17.1.2.3. Market Contribution and BPS Analysis, 2017 & 2027 By Country
    • 17.1.3. By Technology
      • 17.1.3.1. Introduction
      • 17.1.3.2. Cellular Immunotherapy
        • 17.1.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.2.1.1. Market Value Increment Per Year, 2018-2027
        • 17.1.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.1.3.3. Monoclonal Antibodies
        • 17.1.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.3.1.1. Market Value Increment Per Year, 2018-2027
        • 17.1.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.1.3.4. Immune Checkpoint Inhibitors
        • 17.1.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.4.1.1. Market Value Increment Per Year, 2018-2027
        • 17.1.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.1.3.5. Cancer Vaccines
        • 17.1.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.3.6. Cytokine Therapy
        • 17.1.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.6.1.1. Market Value Increment Per Year, 2018-2027
        • 17.1.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.1.3.7. Market Attractiveness Analysis By Technology
      • 17.1.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
    • 17.1.4. By End User
      • 17.1.4.1. Introduction
      • 17.1.4.2. Hospitals
        • 17.1.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.4.2.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.4.3. Ambulatory Surgical Centers (ASCs)
        • 17.1.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.4.3.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.4.4. Clinics
        • 17.1.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.4.5. Others
        • 17.1.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.1.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.1.4.6. Market Attractiveness Analysis By End User
      • 17.1.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
  • 17.2. Latin America
    • 17.2.1. Macro-economic Indicators Impacting the Growth of Latin America Cancer Immunotherapy Market
    • 17.2.2. By Country
      • 17.2.2.1. Brazil, Mexico & rest of LATAM
        • 17.2.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.2.1.1.1. Market Value Increment Per Year, 2017-2027
      • 17.2.2.2. Market Attractiveness Analysis By Country
      • 17.2.2.3. Market Contribution and BPS Analysis, 2017 & 2027 By Country
    • 17.2.3. By Technology
      • 17.2.3.1. Introduction
      • 17.2.3.2. Cellular Immunotherapy
        • 17.2.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.2.1.1. Market Value Increment Per Year, 2018-2027
        • 17.2.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.2.3.3. Monoclonal Antibodies
        • 17.2.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.3.1.1. Market Value Increment Per Year, 2018-2027
        • 17.2.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.2.3.4. Immune Checkpoint Inhibitors
        • 17.2.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.4.1.1. Market Value Increment Per Year, 2018-2027
        • 17.2.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.2.3.5. Cancer Vaccines
        • 17.2.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.3.6. Cytokine Therapy
        • 17.2.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.6.1.1. Market Value Increment Per Year, 2018-2027
        • 17.2.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.2.3.7. Market Attractiveness Analysis By Technology
      • 17.2.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
    • 17.2.4. By End User
      • 17.2.4.1. Introduction
      • 17.2.4.2. Hospitals
        • 17.2.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.2.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.3. Ambulatory Surgical Centers (ASCs)
        • 17.2.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.3.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.4. Clinics
        • 17.2.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.5. Others
        • 17.2.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.6. Market Attractiveness Analysis By End User
      • 17.2.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
  • 17.3. Europe
    • 17.3.1. Macro-economic Indicators Impacting the Growth of Europe Cancer Immunotherapy Market
    • 17.3.2. By Country
      • 17.3.2.1. U.K., Germany & France
        • 17.2.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.5. Others
        • 17.2.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.2.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.2.4.6. Market Attractiveness Analysis By End User
      • 17.2.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
  • 17.3. Europe
    • 17.3.1. Macro-economic Indicators Impacting the Growth of Europe Cancer Immunotherapy Market
    • 17.3.2. By Country
      • 17.3.2.1. U.K., Germany & France
        • 17.3.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.2.1.1.1. Market Value Increment Per Year, 2017-2027
      • 17.3.2.2. Italy, Spain & Russia
        • 17.3.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.2.2.1.1. Market Value Increment Per Year, 2017-2027
      • 17.3.2.3. Poland & Turkey
        • 17.3.2.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.2.3.1.1. Market Value Increment Per Year, 2017-2027
      • 17.3.2.4. BENELUX & Rest of Europe
        • 17.3.2.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.2.4.1.1. Market Value Increment Per Year, 2017-2027
      • 17.3.2.5. Market Attractiveness Analysis By Country
      • 17.3.2.6. Market Contribution and BPS Analysis, 2017 & 2027 By Country
    • 17.3.3. By Technology
      • 17.3.3.1. Introduction
      • 17.3.3.2. Cellular Immunotherapy
        • 17.3.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.2.1.1. Market Value Increment Per Year, 2018-2027
        • 17.3.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.3.3.3. Monoclonal Antibodies
        • 17.3.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.3.1.1. Market Value Increment Per Year, 2018-2027
        • 17.3.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.3.3.4. Immune Checkpoint Inhibitors
        • 17.3.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.4.1.1. Market Value Increment Per Year, 2018-2027
        • 17.3.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.3.3.5. Cancer Vaccines
        • 17.3.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.3.3.6. Cytokine Therapy
        • 17.3.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.6.1.1. Market Value Increment Per Year, 2018-2027
        • 17.3.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.3.3.7. Market Attractiveness Analysis By Technology
      • 17.3.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
    • 17.3.4. By End User
      • 17.3.4.1. Introduction
      • 17.3.4.2. Hospitals
        • 17.3.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.4.2.1.1. Market Value Increment Per Year, 2018-2027
      • 17.3.4.3. Ambulatory Surgical Centers (ASCs)
        • 17.3.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.4.3.1.1. Market Value Increment Per Year, 2018-2027
      • 17.3.4.4. Clinics
        • 17.3.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.3.4.5. Others
        • 17.3.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.3.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.3.4.6. Market Attractiveness Analysis By End User
      • 17.3.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
  • 17.4. Asia Pacific
    • 17.4.1. Macro-economic Indicators Impacting the Growth of Asia Pacific Cancer Immunotherapy Market
    • 17.4.2. By Country
      • 17.4.2.1. India, China & Japan
        • 17.4.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.2.1.1.1. Market Value Increment Per Year, 2017-2027
      • 17.4.2.2. Australia, New Zealand & South Korea
        • 17.4.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.2.2.1.1. Market Value Increment Per Year, 2017-2027
      • 17.4.2.3. Malaysia, Singapore & rest of Asia Pacific
        • 17.4.2.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.2.3.1.1. Market Value Increment Per Year, 2017-2027
      • 17.4.2.4. Market Attractiveness Analysis By Country
      • 17.4.2.5. Market Contribution and BPS Analysis, 2017 & 2027 By Country
    • 17.4.3. By Technology
      • 17.4.3.1. Introduction
      • 17.4.3.2. Cellular Immunotherapy
        • 17.4.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.2.1.1. Market Value Increment Per Year, 2018-2027
        • 17.4.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.4.3.3. Monoclonal Antibodies
        • 17.4.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.3.1.1. Market Value Increment Per Year, 2018-2027
        • 17.4.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.4.3.4. Immune Checkpoint Inhibitors
        • 17.4.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.4.1.1. Market Value Increment Per Year, 2018-2027
        • 17.4.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.4.3.5. Cancer Vaccines
        • 17.4.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.4.3.6. Cytokine Therapy
        • 17.4.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.6.1.1. Market Value Increment Per Year, 2018-2027
        • 17.4.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.4.3.7. Market Attractiveness Analysis By Technology
      • 17.4.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
    • 17.4.4. By End User
      • 17.4.4.1. Introduction
      • 17.4.4.2. Hospitals
        • 17.4.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.4.2.1.1. Market Value Increment Per Year, 2018-2027
      • 17.4.4.3. Ambulatory Surgical Centers (ASCs)
        • 17.4.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.4.3.1.1. Market Value Increment Per Year, 2018-2027
      • 17.4.4.4. Clinics
        • 17.4.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.4.4.5. Others
        • 17.4.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.4.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.4.4.6. Market Attractiveness Analysis By End User
      • 17.4.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User
  • 17.5. Middle East & Africa
    • 17.5.1. Macro-economic Indicators Impacting the Growth of Middle East & Africa Cancer Immunotherapy Market
    • 17.5.2. By Country
      • 17.5.2.1. GCC, Israel & North Africa
        • 17.5.2.1.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.2.1.1.1. Market Value Increment Per Year, 2017-2027
      • 17.5.2.2. South Africa & Rest of Middle East & Africa
        • 17.5.2.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.2.2.1.1. Market Value Increment Per Year, 2017-2027
      • 17.5.2.3. Market Attractiveness Analysis By Country
      • 17.5.2.4. Market Contribution and BPS Analysis, 2017 & 2027 By Country
    • 17.5.3. Middle East & Africa Cancer Immunotherapy Market Segmentation Analysis By Technology
      • 17.5.3.1. Introduction
      • 17.5.3.2. Cellular Immunotherapy
        • 17.5.3.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.2.1.1. Market Value Increment Per Year, 2018-2027
        • 17.5.3.2.1.1.1. CAR T-Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.2.1.1.2. Dendritic Cell Therapy Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.5.3.3. Monoclonal Antibodies
        • 17.5.3.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.3.1.1. Market Value Increment Per Year, 2018-2027
        • 17.5.3.3.1.1.1. Naked Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.3.1.1.2. Conjugated Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.3.1.1.2.1. Radiolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.3.1.1.2.2. Chemolabeled antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.3.1.1.3. Bispecific Monoclonal Antibodies Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.5.3.4. Immune Checkpoint Inhibitors
        • 17.5.3.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.4.1.1. Market Value Increment Per Year, 2018-2027
        • 17.5.3.4.1.1.1. PD-1/PD-L1 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.4.1.1.2. CTLA-4 Inhibitors Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.5.3.5. Cancer Vaccines
        • 17.5.3.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.5.3.6. Cytokine Therapy
        • 17.5.3.6.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.6.1.1. Market Value Increment Per Year, 2018-2027
        • 17.5.3.6.1.1.1. Interleukins Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.3.6.1.1.2. Interferons Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
      • 17.5.3.7. Market Attractiveness Analysis By Technology
      • 17.5.3.8. Market Contribution and BPS Analysis, 2017 & 2027 By Technology
    • 17.5.4. Middle East & Africa Cancer Immunotherapy Market Segmentation Analysis By End User
      • 17.5.4.1. Introduction
      • 17.5.4.2. Hospitals
        • 17.5.4.2.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.4.2.1.1. Market Value Increment Per Year, 2018-2027
      • 17.5.4.3. Ambulatory Surgical Centers (ASCs)
        • 17.5.4.3.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.4.3.1.1. Market Value Increment Per Year, 2018-2027
      • 17.5.4.4. Clinics
        • 17.5.4.4.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.4.4.1.1. Market Value Increment Per Year, 2018-2027
      • 17.5.4.5. Others
        • 17.5.4.5.1. Market Value Forecast (USD Million) & Y-o-Y Growth (%), 2017-2027
        • 17.5.4.5.1.1. Market Value Increment Per Year, 2018-2027
      • 17.5.4.6. Market Attractiveness Analysis By End User
      • 17.5.4.7. Market Contribution and BPS Analysis, 2017 & 2027 By End User

18. Competitive Landscape

  • 18.1. Competitive Positioning of Major Players in Global Cancer Immunotherapy Market
  • 18.2. Company Profiles
    • 18.2.1. AstraZeneca
      • 18.2.1.1. Company Overview
      • 18.2.1.2. Business Strategy
      • 18.2.1.3. Key Product Offerings
      • 18.2.1.4. Financial Performance
      • 18.2.1.5. Key Performance Indicators
      • 18.2.1.6. Risk Analysis
      • 18.2.1.7. Recent Development
      • 18.2.1.8. Regional Presence
      • 18.2.1.9. SWOT Analysis
    • 18.2.2. Merck & Co.
    • 18.2.3. Novartis
    • 18.2.4. Advaxis Inc
    • 18.2.5. Bristol-Myers Squibb (BMS)
    • 18.2.6. Bayer AG
    • 18.2.7. Roche
    • 18.2.8. Eli Lilly and Co.
    • 18.2.9. Amgen Inc
    • 18.2.10. Pfizer Inc

19. Guide to the Industry by Region & Analyst's Recommendations

Back to Top